Your session is about to expire
← Back to Search
Prehabilitation Program for Head and Neck Cancer
Study Summary
This trial is testing a new way to help people with head and neck cancer that focuses on their quality of life. The current treatment is extremely rigorous and has a profound impact on patients' physical, social, and emotional functioning, often leading to decreased functional capacity and decreased quality of life. The new approach being tested seeks to improve treatment and outcomes by providing personalized education and interventions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are currently receiving treatment with an external defibrillator.I am 18 years old or older.I have a heart rhythm problem and have a pacemaker.I am currently seeking treatment to cure my cancer.You are allergic to metal.I have been diagnosed with head and neck cancer.You have another electronic device implanted in your body.
- Group 1: Prospective Prehabilitation
- Group 2: Prospective Control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are medical facilities currently recruiting participants for this trial?
"Affirmative. The information posted on clinicaltrials.gov illustrates that this study is currently recruiting participants, which was initially published on October 21st 2021 and recently modified on November 2nd 2022. 80 volunteers are needed across two different medical sites."
What aims is this research project seeking to accomplish?
"This clinical trial will track the primary outcome of Study Completion over a period that ranges from Baseline, post-treatment (2 weeks to 6 months), and 6-months follow-up. The secondary outcomes involve determining sarcopenia's impact on functioning with bioimpedence spectroscopy technology (BIS) as well as testing functional assessments such as sit to stand test, grip strength, and two minute walk tests; noting changes in Columbia-Suicide Severity Rating Scale score between baseline and after treatment; measuring variations in Behavioral Health Screening 6 scores pre/post intervention."
How many individuals are actively engaging in the clinical experimentation?
"Affirmative. The clinical trial database hosted on clinicaltrials.gov illustrates that the study, which was first published on October 21st 2021, is actively searching for participants. A total of 80 patients need to be enrolled from two respective sites."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger